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Cardiac involvement in myotonic dystrophy type 1 (DM1) is frequent with increased incidence of conduction disturbances and sudden
cardiac death when compared with general population. We describe a 38-year-old man in whom the diagnosis of DM1 was made
8 years after occurrence of cardiac arrest owing to ventricular fibrillation and discuss management of DM1 patients at risk for
sudden cardiac death.
Introduction
Patients with myotonic dystrophy type 1 (DM1) typically develop atrioventricular blocks, atrial, and ventricular arrhythmias.1–4 The
incidence of sudden cardiac death is increased compared with the general population.1 The identification of patients at risk for sudden
cardiac death is still challenging, even though larger cytosine-thymine-guanine trinucleotide repeat expansions and ECG abnormalities
(rhythm other than sinus, PR interval  240 ms, second-third degree AV block, QRS  120 ms) were found to be associated with an
increased risk of major cardiac events.1,2,4
Case report
At age 16, the patient presented a brief loss of consciousness while playing soccer. No investigations were performed at that time. He
continued to play soccer until age 25 when, again during a soccer game, he had a syncope associated with an episode of paroxysmal
atrial fibrillation. ECG, echocardiogram, stress test, Holter recording, and EEG were within normal limits. He was discharged with no
specific diagnosis. Two years later, he had a cardiac arrest (CA) while playing soccer caused by ventricular fibrillation (VF). He was
resuscitated on the field with basic life support measures and DC-shock and admitted to the hospital, without neurological impair-
ment. No major arrhythmias were subsequently detected and ECG was normal. Echocardiogram showed marked right ventricular
trabeculae. Coronary angiography did not reveal coronary artery anomalies. At right ventricular angiography, areas of wall motion
abnormalities of mild extent were noted with evidence of apical trabeculae. Right ventricle myocardial biopsy revealed mild fibrosis
and myocyte hypertrophy, but no fatty infiltrations. Cardiac magnetic resonance imaging (MRI) was reported to show non-specific
findings. Electrophysiological study (EPS) showed: normal sinus node function and AV conduction; programmed ventricular stimulation
did not induce ventricular tachycardia (VT) or VF. The exercise test did neither provoke major atrial and/or ventricular arrhythmias
nor repolarization abnormalities. The patient was discharged on nadolol.
Eight years after the CA, the patient was referred to our Institution (out-patient Neuromuscular Clinic) to rule out the diagnosis of
DM1, which had been made in his twin brother at that time. Since the CA he stopped playing soccer and did not complain any cardiac
symptoms except occasional well-tolerated short episodes of palpitations. Cardiac assessment (ECG, echocardiogram, 24-h Holter
monitoring) did not reveal abnormalities. Myotonia, distal muscle weakness, and cataracts fulfilled clinical diagnostic criteria for
DM1, which was confirmed by genetic testing [cytosine-thymine-guanine repeat (CTGn ¼ 5/812)].
During the subsequent 4 years follow-up, the clinical status of the patient did not substantially change. However, considering the
history of previous CA a cardiac re-evaluation was advised. ECG, echocardiogram, and Holter monitoring were within normal limits.
Repeat EPS showed: normal sinus node function and A-V conduction times (AH interval ¼ 92 ms; HV ¼ 42 ms); atrial stimulation
induced a typical clockwise atrial flutter (cavo-tricuspid isthmus-dependent), which was reproducible; programmed ventricular stimu-
lation was unable to induce VT or VF. Cardiac MRI imaging showed normal size and function of both ventricles.
Discussion
Our case had two not well-defined syncopal episodes and one resuscitated CA due to VF, most likely related to DM1 predisposing
arrhythmia occurrence. For these reasons, if recent international guidelines5 had been applied at the time of CA, the patient would
probably have had a cardioverter defibrillator (ICD) implanted. On the other hand, no further episode occurred during the 12-year
follow-up period. In addition, except for the occurrence of atrial fibrillation at age 25, ECG-predictive factors for sudden cardiac death
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in DM1 subjects, recently reported by Groh et al.,2 were not present in our patient. EPS was negative in two occasions and did not
provide specific indications regarding the need for more invasive preventive treatments like pacemaker or ICD implantation. Never-
theless, considering the recent guidelines5 that recommend ICD implantation in patients who are survivors of CA owing to VF, and the
fact that DM1 patients, particularly with large number of CTG repeats, as our patient, have a higher rate of ventricular ectopy and of
conduction defect progression, we decided to implant an ICD. However, in the proband’s twin, who had more severe muscle
weakness, but no cardiac involvement (no ECG abnormalities, normal echocardiogram and MRI, negative EPS, which was performed
considering the family history of CA), and never presented syncope, CA, or major arrhythmia, our treatment strategy was to follow-up
the patient, monitoring the appearance of cardiac symptoms and ECG abnormalities.
In conclusion, our report confirms that CA is a possible event in adult patients with DM1 even in the absence of structural cardiac
involvement. On the other hand, patients, as our proband, may remain asymptomatic after a resuscitated CA for very long period of
time, yet bearing the potential risk of life-threatening arrhythmias, which justifies ICD implantation.
Conflict of interest: none declared.
References
1. Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med
2008; 358: 2688–97.
2. Groh WJ, Lowe MR, Zipes DP. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length.
J Cardiovasc Electrophysiol 2002; 13: 444–8.
3. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter
diagnostic pacemaker study. J Am Coll Cardiol 2002; 40: 1645–52.
4. Cudia P, Bernasconi P, Chiodelli R, Mangiola F, Bellocci F, Dello Russo A et al. Risk of arrhythmia in type 1 myotonic dystrophy: the role of clinical and genetic variables.
J Neurol Neurosurg Psychiatry; Epub ahead of print 22 February 2009; doi:10.1136/jnnp.2008.162594.
5. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrythmias and
the prevention of sudden cardiac death. A report of the American College of Cardiology/America Heart Association Task Force and the European Society of Cardiology
Committee for Practice Guidelines. Eur Heart J 2006; 27: 2099–141.
 by guest on O
ctober 10, 2012
http://europace.oxfordjournals.org/
D
ow
nloaded from
 
